RT-PCR analysis of corticotroph-associated genes expression in carcinoid tumours in the ectopic-ACTH syndrome

European Journal of Endocrinology

Volumn 154, Issue 1, 2006, Pages 159-166

  Messager, M ^b   Carriere C ^b   Bertagna, X ^b   de Keyzer, Y ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; CORTICOTROPIN; GLUCOCORTICOID RECEPTOR ALPHA; NEUROGENIC DIFFERENTIATION FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PIT 1; TUMOR MARKER; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 1; NUCLEAR RECEPTOR NUR77; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 1; PROTEIN TPIT; TRANSCRIPTION FACTOR PITX1;

ADULT; AGED; ARTICLE; CARCINOID; CLINICAL ARTICLE; ECTOPIC CORTICOTROPIN PRODUCTION; FEMALE; GENE EXPRESSION; GENETIC MARKER; GENETIC TRANSCRIPTION; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; LUNG TUMOR; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; THYMOMA; ALTERNATIVE RNA SPLICING; CONTROLLED STUDY; CORTICOTROPIN RELEASE; GENE EXPRESSION PROFILING; LUNG CARCINOID; PROTEIN EXPRESSION; THYMUS CARCINOID; TRANSCRIPTION REGULATION; TUMOR DIFFERENTIATION;

ACTH SYNDROME, ECTOPIC; ADULT; AGED; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRONCHIAL NEOPLASMS; CARCINOID TUMOR; COUP TRANSCRIPTION FACTOR I; FEMALE; GENE EXPRESSION; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; PAIRED BOX TRANSCRIPTION FACTORS; PPAR GAMMA; RECEPTORS, GLUCOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 32844473313     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02077     Document Type: Article

References (36)

1. Odell W. Endocrine/metabolic syndromes of cancer. Seminars in Oncology 1997 24 299-317.
2. Marchioli C & Graziano S. Paraneoplastic syndromes associated with small cell lung cancer. Chest Surgery and Clinics of North America 1997 7 65-80.
3. Meador CK, Liddle GW Island DP, Nicholson WE, Lucas CP, Nuckton JG & Luetscher JA. Cause of Cushing's syndrome in patients with tumors arising from 'neuroendocrine' tissue. Journal of Clinical Endocrinology and Metabolism 1962 22 693-703.
4. Lacaze-Masmonteil T, de Keyzer Y, Luton JP, Kahn A & Bertagna X. Characterization of proopiomelanocortin transcripts in human nonpituitary tissues. PNAS 1987 84 7261-7265.
5. DeBold CR, Menefee JK, Nicholson WE & Orth DN. Proopiomelanocortin gene is expressed in many normal human tissues and in tumors not associated with the ectopic adrenocorticotropin syndrome. Molecular Endocrinology 1988 2 862-870.
6. Clark AJL, Lavender PM, Coates P, Johnson MR & Rees LH. In vitro and in vivo analysis of the processing and fate of the peptide products of the short proopiomelanocortin mRNA. Molecular Endocrinology 1990 4 1737-1743.
7. de Keyzer Y, Bertagna X, Luton JP & Kahn A. Variable modes of proopiomelanocortin gene transcription in human tumors. Molecular Endocrinology 1989 3 215-223.
8. Texier PL, deKeyzer Y, Lacave R, Vieau D, Lenne F, Rojas-Miranda A, Verley JM, Luton JP, Kahn A & Bertagna X. Proopiomelanocortin gene expression in normal and tumoral human lung. Journal of Clinical Endocrinology and Metabolism 1991 73 414-420.
9. Monig H, Ali I, Oldfield E & Schulte H. Structure of the POMC promoter region in pituitary and extrapituitary ACTH producing tumors. Experimental and Clinical Endocrinology 1993 101 36-38.
10. Therrien M & Drouin J. Cell-specific helix-loop-helix factor required for pituitary expression of the pro-opiomelanocortin gene. Molecular and Cellular Biology 1993 13 2342-2353.
11. Lamonerie T, Tremblay JJ, Lanctôt C, Therrien M, Gauthier Y & Drouin J. Ptx1, a bicoid-related homeo box transcription factor involved in the transcription of the pro-opiomelanocortin gene. Genes and Development 1996 10 1284-1295.
12. Philips A, Maira M, Mullick A, Chamberland M, Lesage S, Hugo P & Drouin J. Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Molecular and Cellular Biology 1997 17 5952-5959.
13. Poulin G, Turgeon B & Drouin J. NeuroD1/β2 contributes to cell-specific transcription of the proopiomelanocortin gene. Molecular and Cellular Biology 1997 17 6673-6682.
14. Lamolet B, Pulichino A, Lamonerie T, Gauthier Y, Brue T, Enjalbert A & Drouin J. A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 2001 104 849-859.
15. Paez-Pereda M, Kovalovsky D, Hopfner U, Theodoropoulou M, Pagotto U, Uhl E, Losa M, Stalla J, Grubler Y, Missale C, Arzt E & Stalla G. Retinoic acid prevents experimental Cushing's syndrome. Journal of Clinical Investigation 2001 108 1123-1131.
16. Heaney A, Fernando M, Yong W & Melmed S. Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas. Nature Medicine 2002 8 1281-1287.
17. Heaney A, Fernando M, Yong W & Melmed S. PPAR-gamma receptor ligands: novel therapy for pituitary adenomas. Journal of Clinical Investigations 2003 111 1381-1388.
18. de Keyzer Y, Clauser E & Bertagna X. The pituitary V3 vasopressin receptor and the ectopic corticotropin syndrome. Current Opinion in Endocrinology and Diabetes 1996 3 125-131.
19. de Keyzer Y, Raffin-Sanson M, Picon A & Bertagna X. Syndromes of ectopic ACTH secretion - recent pathophysiological aspects. In Adrenal Disorders, pp 165-177. Eds N Margioris & G Chrousos. Totowa, NJ: Humana Press, 2001.
20. de Keyzer Y, Bertagna X, Lenne F, Girard F, Luton J-P & Kahn A. Altered proopiomelanocortin gene expression in adrenocorticotropin-producing non-pituitary tumors. Journal of Clinical Investigation 1985 76 1892-1898.
21. de Keyzer Y, Lenne F, Auzan C, Jégou S, René P, Vaudry H, Kuhn J-M, Luton J-P, Clauser E & Bertagna X. The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome. Journal of Clinical Investigation 1996 97 1311-1318.
22. Pascual-Le Tallec L, Dulmet E, Bertagna X & de Keyzer Y. Identification of genes associated with the corticotroph phenotype in bronchial carcinoid tumors. Journal of Clinical Endocrinology and Metabolism 2002 87 5015-5022.
23. Dahia PLM, Ahmed-Shuaib A, Jacobs RA, Chew SL, Honegger J, Fahlbusch R, Besser GM & Grossman AB. Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors. Journal of Clinical Endocrinology and Metabolism 1996 81 1768-1771.
24. Dieterich KD, Gundelfinger ED, Lüdeke DK & Lehnert H. Mutation and expression analysis of corticotropin-releasing factor 1 receptor in adrenocorticotropin-secreting pituitary tumors. Journal of Clinical Endocrinology and Metabolism 1998 83 3327-3331.
25. Elbrecht A, Chen Y, Cullman C, Hayes N, Leibowitz M, Moller D & Berger J. Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochemical and Biophysical Research Communications 1996 224 431-437.
26. Picon A, Bertagna X & de Keyzer Y. Analysis of proopiomelanocortin gene transcription mechanisms in bronchial tumor cells. Molecular and Cellular Endocrinology 1999 147 93-102.
27. Picon A, Bertagna X & de Keyzer Y. Analysis of the human proopiomelanocortin gene promoter in a small cell lung carcinoma cell line reveals an unusual role for E2F transcription factors. Oncogene 1999 18 2627-2633.
28. North WG, Fay MJ, Longo KA & Du J. Expression of all known vasopressin receptor subtypes by small cell tumors implies a multifaceted role for this neuropeptide. Cancer Research 1998 58 1866-1871.
29. Chabot V, de Keyzer Y, Gebhard S, Uské A, Bischof-Delaloye A, Rey F, Dusmet M & Gomez F. Ectopic ACTH Cushing's syndrome: vasopressin but not CRH receptor gene expression in a pulmonary carcinoid tumor. Hormone Research 1998 50 226-231.
30. Vallette-Kasic S, Figarella-Branger D, Grino M, Pulichino A, Dufour H, Grisoli F, Enjalbert A, Drouin J & Brue T. Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatons human corticotrophs. Journal of Clinical Endocrinology and Metabolism 2003 88 3050-3056.
31. Ueda Y, Bandoh S, Fujita J, Sato M, Yamaji Y & Takahara J. Expression of nerve growth factor-induced clone B subfamily and pro-opiomelanocortin gene in lung cancer cell lines. American Journal of Respiration and Cellular Molecular Biology 1999 20 1319-1325.
32. Okabe T, Takayanagi R, Adachi M, Imasaki K & Nawata H. Nur 77, a member of the steroid receptor superfamily, antagonizes negative feedback of ACTH synthesis and secretion by glucocorticoid in pituitary corticotrope cells. Journal of Endocrinology 1998 156 169-175.
33. Drouin J, Maira M & Philips A. Novel mechanism of action of Nur77 and antagonism by glucocorticoids: a convergent mechanism for CRH activation and glucocorticoid repression of POMC gene transcription. Journal of Steroid Biochemistry and Molecular Biology 1998 65 59-63.
34. Karl M, Von Wichert G, Kempter E, Katz D, Reincke M, Monig H, Ali I, Stratakis C, Oldfield E, Chrousos G & Schulte H. Nelson's syndrome associated with a somatic frame shift mutation in the glucocorticoid receptor gene. Journal of Clinical Endocrinology and Metabolism 1996 81 124-129.
35. Dahia PLM, Honegger J, Reincke M, Jacobs RA, Mirtella A, Fahlbusch R, Besser GM, Chew SL & Grossman A. Expression of glucocorticoid receptor gene isoforms in corticotropin-secreting tumors. Journal of Clinical Endocrinology and Metabolism 1997 82 1088-1093.
36. Gaitan D, DeBold CR, Turney MK, Zhou P, Orth DN & Kovacs WJ. Glucocorticoid receptor structure and function in an adrenocorticotropin-secreting small cell lung cancer. Molecular Endocrinology 1995 9 1193-1201.